Advancing the Science of Native Biological Systems.

Our focus is on unlocking the potential of native biological systems. We use cutting-edge science and technology to understand human biology and evaluate native tissue-derived candidates that support structural integrity and tissue management.

Skye believes the future of regenerative support lies within native biologic structures. Specifically, Skye Biologics is committed to advancing scientific research into the functional properties of human tissue and extracellular matrix (ECM) structures to support recovery, repair, and tissue integrity in complex clinical settings.

To help address high healthcare costs across $100+ billion in annual spending, Skye evaluates versatile tissue platforms and extracellular matrices for both surgical and non-surgical applications. Our goal is to provide high-quality biological options across musculoskeletal structures, soft tissue boundaries, and areas of high clinical need, helping optimize utility while supporting cost-effective care.

A leader in tissue technology since 2010, Skye has established a strong legacy as an independent biotechnology company, supplying hundreds of thousands of human tissue allografts and ECM matrices across the U.S., grounded in rigorous quality and compliance standards.

  
      Imagine in the future: altering one's biology to quickly repair a tear (ACL, shoulder, bicep, etc)
      Imagine in the future: eliminating back and joint pain
      Imagine in the future: rejuvenating tissues and extending lifespan by restoring function
      Imagine in the future: recovering rapidly post-surgery with reduced pain and scarring

As tissue ages, its structural integrity and natural remodeling capacity decreases. Utilizing innovative science, Skye is investing in and evaluating future advanced solutions designed to provide structural support and complement the body's natural repair environment.

The natural tissue repair process:

Injuries, degeneration, comorbidities, or compromised host tissue can impair matrix integrity and structural remodeling.

Initial Injury

Uncontrolled Inflammation

Disorganized Tissue / Scar Tissue Formation

Risk of Failure

Translational Science: Skye’s research is focused on developing solutions to help the body achieve proper repair:

Modulate Inflammation

Collagen Scaffold

Ideal Environment

Proper Remodeling

Next-generation platform: Active research & candidate pipeline

A robust research pipeline leveraging state-of-the-art science focused on the pursuit of transformative candidates. We are dedicated to advancing our scientific understanding of native tissue solutions to evaluate future solutions that support clinical utility, patient quality of life, and long-term health outcomes.